Implantable Biomaterials Market Forecasts to 2028 – Global Analysis By Material Type (Ceramics, Metals), Application Type (Dental, Ophthalmology), End User (Hospitals, Specialty Clinics) and By Geography
According to Stratistics MRC, the Global Implantable Biomaterials Market is accounted for $113.05 billion in 2022 and is expected to reach $224.34 billion by 2028 growing at a CAGR of 12.1% during the forecast period. Implantable Biomaterials are artificially derived synthetic or natural materials that are used in medical technology to improve the functionality of damaged tissues and organs. These biological materials are used in medical device or implants which enhances or replace any natural bodily functions. Implantable biomaterials are engineered to take up the form of anybody’s function. As the body does not accept completely any foreign material to augment its biological functions, implantable biomaterials are designed in a way to reduce the negative immune response given by the body while maintaining adequate function. Moreover, biomaterials science can be implemented in various advanced medical technologies such, tissue engineering, plastic surgery, drug delivery devices, and other medical implants.
In 2017, the global market value of metal based biomaterials was 20.11 billion U.S. dollars, and it is forecasted to increase to nearly 35 billion U.S. dollars in 2021. Biomaterials refer to any substance that has been designed to interact with biological systems for medical purposes, whether it is diagnostic or therapeutic. In 2017, the global market value of biomaterials was 83.76 billion U.S. dollars and it is forecasted to increase to nearly 152 billion U.S. dollars in 2021.
Market Dynamics:
Driver:
The increase in the geriatric population
The increase in the geriatric population, increase awareness regarding the advantages of biomaterials products and increase the production of implantable products, and advancements in medical technology are the key drivers of the market. Moreover, porous-coated and fully or partially porous orthopaedic implants have gained significant popularity in recent years. This is because of the excellent property of the porous structures to reduce the elastic modulus and stimulate bone growth around the implant. 3-D printing, powder metallurgy, and additive manufacturing are some of the potential techniques to manufacture porous metallic and ceramic implants.
Restraint:
Limitations of biomaterial-based products
Limitations of biomaterial-based products may be a major challenge for the implantable biomaterials market. Also, metal biomaterials can corrode due to chemical and biological reactions within the body such as enzymes and acids or it can also lead to some metal ion toxicity in the body. Polymer biomaterial implants have intensive interaction with the body and may cause wear and tear and may absorb the important nutrients and water from the blood.
Opportunity:
Favorable reimbursements for implantable biomaterials
Favorable reimbursements for implantable biomaterials are another factor driving the implantable biomaterials global market. However, most of the implantable biomaterials trigger acute or chronic inflammatory responses in the body. Advanced technologies have produced biomaterials that can interact with the body's biological system and perform various functions like transportation of bioactive molecules has increased the demand and market value of the products.
Threat:
Huge disasters or personal misfortunes for the patient
The reactions can black a biomaterial and even lead to huge disasters or personal misfortunes for the patient this factor is restraining the growth of implantable biomaterial market. Metallic biomaterials might corrode underexposure of various chemical and biological reactions; polymer biomaterials can cause wear and tear and absorb nutrients molecules. These impacts of the implantable biomaterials can impact the market growth.
Covid-19 Impact
The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
The synthetic polymers segment is expected to have the highest CAGR during the forecast period
The synthetic polymers segment is growing at the highest CAGR in the market. Synthetic polymers are high-molar-mass substances formed by the linkage of several small monomers. Polymers can be naturally occurring or synthetic. Synthetic polymers are replacing other materials such as metals, ceramics, and alloys due to their superior physicochemical properties. These polymers are non-toxic, non-carcinogenic, and non-immunogenic, and possess excellent biocompatibility. They are used for a wide range of applications such as diagnostic supports, drug delivery systems, and as a useful material for tissue engineering.
The metals and metal alloys segment is expected to be the largest during the forecast period
The metals and metal alloys segment is expected to be the largest share during the forecast period due to chemical reactions within the body such as enzymes and acids or it can also cause some metal ion toxicity in the body.
Region with highest share:
The Asia Pacific is projected to hold the largest share in the market. The rising growth of the biomaterials market in this region includes Japan’s growing healthcare industry, increasing geriatric population, rising prevalence of cardiovascular diseases, increasing cases of hip & knee replacement procedures, rising cosmetic & plastic surgeries, and growing research activities will boost the market in the APAC region.
Region with highest CAGR:
North America is projected to have the highest CAGR in the market due to the factors such as the increasing aging population, new product innovations, and increase in government investments in the biomaterial sector.
Key players in the market
Some of the key players profiled in the Implantable Biomaterials Market include 3M, AdvanSource Biomaterials Corporation, Arthrex, BASF SE, Bayer AG, Berkeley Advanced Biomaterials, Biomet, Cam Bioceramics B.V., Carpenter Technology Corporation, Celanese Corporation, CeramTec, Linden, Collagen Solutions Plc, CoorsTek Inc., E.I. DuPont De Nemours and Company, Evonik Industries AG, Royal DSM, Stryker Corporation, Zimmer Biomet Holdings, and Medtronic.
Key developments:
In January 2021: Stryker acquired OrthoSensor. Smart devices and implants will play a big role in orthopaedics and it is excited for OrthoSensor to join Stryker as it continues to innovate and advance smart sensor technologies, including intraoperative sensors, wearables and smart implants across the joint replacement business.
In August 2019: Linden, a US-based healthcare private equity firm, acquired Collagen Matrix Inc for an undisclosed amount. The acquisition is expected to be an operating partner-driven strategy and highlights their ongoing focus on medical products, and contract and private label manufacturing in dental and orthopaedic sectors.
Material Types Covered:
• Ceramics
• Natural Biomaterials
• Composites
• Metals and Metal Alloys
• Synthetic Polymers
Application Types Covered:
• Cardiology/Cardiovascular
• Dental
• Ophthalmology
• Orthopedics
• Plastic Surgery
• Wound Healing
End Users Covered
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook